drugset / Trial / NCT04487925

Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders

NCT04487925

Phase 4 Unknown 208 enrolled University Hospital, Ghent
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a prospective, randomized, single center, phase 4 controlled trial. The study will compare the efficacy of two different strategies for the management of predicted poor response patients under stimulation for IVF/ICSI: up to three MNC cycles (group 1) versus a single GnRH antagonist CFA (group 2).

Timeline

Start
2022-01-25
Primary completion
2024-09-30
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Corifollitropin alfa Protein / enzyme biologic
Comparator Follitropin beta Protein / enzyme biologic

Indications